Drugs / GR1405
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03731390 | Nov 2018 → Oct 2019 | lymphoma, soft tissue neoplasm | Chinese Academy of Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GR1405 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03731390 ↗ |